These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18702973)

  • 1. Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion.
    Kim ES; Carrigan TP; Menon V
    J Am Coll Cardiol; 2008 Aug; 52(8):672-3. PubMed ID: 18702973
    [No Abstract]   [Full Text] [Related]  

  • 2. International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.
    Kim ES; Carrigan TP; Menon V
    J Am Coll Cardiol; 2011 Aug; 58(7):671-6. PubMed ID: 21816301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.
    Harris DJ; Douglas PS
    N Engl J Med; 2000 Aug; 343(7):475-80. PubMed ID: 10944565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why should we include women and minorities in randomized controlled trials?
    Weijer C; Crouch RA
    J Clin Ethics; 1999; 10(2):100-6. PubMed ID: 10633280
    [No Abstract]   [Full Text] [Related]  

  • 5. American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?
    Califf RM; Harrington RA
    J Am Coll Cardiol; 2011 Aug; 58(7):677-80. PubMed ID: 21816302
    [No Abstract]   [Full Text] [Related]  

  • 6. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 7. $1 billion to the National Heart, Lung, and Blood Institute: economic stimulus or bust?
    Galani RJ
    J Am Coll Cardiol; 2011 Feb; 57(7):889; author reply 889. PubMed ID: 21310329
    [No Abstract]   [Full Text] [Related]  

  • 8. National Heart, Lung, and Blood Institute and the American Recovery and Reinvestment Act of 2009: 1 year later.
    Lauer MS
    J Am Coll Cardiol; 2010 Jul; 56(3):234-6. PubMed ID: 20620744
    [No Abstract]   [Full Text] [Related]  

  • 9. Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute.
    Gordon D; Cooper-Arnold K; Lauer M
    J Am Heart Assoc; 2015 Jul; 4(8):e002292. PubMed ID: 26231845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
    Douglas PS; Taylor A; Bild D; Bonow R; Greenland P; Lauer M; Peacock F; Udelson J
    J Cardiovasc Comput Tomogr; 2009; 3(4):212-23. PubMed ID: 19577208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute.
    Buxton DB; Skarlatos SI
    Circ Res; 2012 Jun; 110(12):1549-55. PubMed ID: 22679137
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies comparing treatment options receive a boost.
    Nair P
    Nat Med; 2009 May; 15(5):468. PubMed ID: 19424190
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanotechnology research support at the National Heart, Lung, and Blood Institute.
    Buxton DB
    Circ Res; 2011 Jul; 109(3):250-4. PubMed ID: 21778434
    [No Abstract]   [Full Text] [Related]  

  • 14. Reporting and representation of race/ethnicity in published randomized trials.
    Berger JS; Melloni C; Wang TY; Dolor RJ; Frazier CG; Samad Z; Peterson ED; Mark DB; Newby LK
    Am Heart J; 2009 Nov; 158(5):742-7. PubMed ID: 19853691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect Sizes and Primary Outcomes in Large-Budget, Cardiovascular-Related Behavioral Randomized Controlled Trials Funded by NIH Since 1980.
    Irvin VL; Kaplan RM
    Ann Behav Med; 2016 Feb; 50(1):130-46. PubMed ID: 26507906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the research landscape require a new approach, while continuing to fund the highest scientific priorities. Jennifer Taylor talks with Dr Elizabeth Nabel, Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) National Library.
    Nabel E
    Eur Heart J; 2009 Jun; 30(12):1423-5. PubMed ID: 19533911
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in heart failure: Minnesota's role in the NHLBI's Heart Failure Network.
    Bart BA
    Minn Med; 2008 Jan; 91(1):40-2. PubMed ID: 18269068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface. Randomized clinical trials.
    Waclawiw MA; Wu CO; Yang S
    Stat Med; 2012 Nov; 31(25):2937. PubMed ID: 23055179
    [No Abstract]   [Full Text] [Related]  

  • 19. The AJH visits NIH.
    Alderman MH
    Am J Hypertens; 2011 Apr; 24(4):372-3. PubMed ID: 21423127
    [No Abstract]   [Full Text] [Related]  

  • 20. Population-based cohort studies: still relevant?
    Sorlie P; Wei GS
    J Am Coll Cardiol; 2011 Nov; 58(19):2010-3. PubMed ID: 22032715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.